
-
Field of Gold sparkles on opening day of Royal Ascot
-
Alcaraz wins testing Queen's opener, Draper cruises
-
'Second time I've died': Nobel laureate Jelinek denies death reports
-
Oil prices jump, stocks drop as traders track Israel-Iran crisis
-
Swiss insurers estimate glacier damage at $393 mn
-
Premiership club Gloucester sign All Blacks prop Laulala
-
Spain says 'overvoltage' caused huge April blackout
-
Russian strikes kill 10 in 'horrific' attack on Kyiv
-
Record stand puts Bangladesh in command in first Sri Lanka Test
-
Galthie defends second-string France squad for New Zealand tour
-
China's Xi in Kazakhstan to cement 'eternal' Central Asia ties
-
How much damage has Israel inflicted on Iran's nuclear programme?
-
Male victim breaks 'suffocating' silence on Kosovo war rapes
-
Disgraced referee Coote charged by FA over Klopp remarks
-
Queer astronaut documentary takes on new meaning in Trump's US
-
UK startup looks to cut shipping's carbon emissions
-
Roma not aiming for Serie A title 'but you never know', says Gasperini
-
UK automakers cheer US trade deal, as steel tariffs left in limbo
-
Pope Leo XIV to revive papal holidays at summer palace
-
French ex-PM Fillon given suspended sentence over wife's fake job
-
US retail sales slip more than expected after rush to beat tariffs
-
Farrell has no regrets over short France stint with Racing 92
-
Global oil demand to dip in 2030, first drop since Covid: IEA
-
Indonesia volcano spews colossal ash tower, alert level raised
-
Dutch suggest social media ban for under-15s
-
Russian strikes kill 16 in 'horrific' attack on Kyiv
-
Gaza rescuers say Israel army kills more than 50 people near aid site
-
Tehranis caught between fear and resolve as air war intensifies
-
Oil prices rally, stocks slide as traders track Israel-Iran crisis
-
Sweden's 'Queen of Trash' jailed over toxic waste scandal
-
Trump says wants 'real end' to Israel-Iran conflict, not ceasefire
-
Poll finds public turning to AI bots for news updates
-
'Spectacular' Viking burial site discovered in Denmark
-
Why stablecoins are gaining popularity
-
Man Utd CEO Berrada sticking to 2028 Premier League title aim
-
Iraq treads a tightrope to avoid spillover from Israel-Iran conflict
-
Payback time: how Dutch players could power Suriname to the World Cup
-
Oil prices rally, stocks mixed as traders track Israel-Iran crisis
-
Bank of Japan holds rates, will slow bond purchase taper
-
Thai cabinet approves bid to host Bangkok F1 race
-
Oil prices swing with stocks as traders keep tabs on Israel-Iran crisis
-
Amsterdam honours its own Golden Age sculpture master
-
Russian strikes kill 14 in 'horrific' attack on Kyiv
-
Taiwan tests sea drones as China keeps up military pressure
-
Survivors of Bosnia 'rape camps' come forward 30 years on
-
Australian mushroom murder suspect told 'lies upon lies': prosecutor
-
Israel, Iran trade blows as air war rages into fifth day
-
'Farewell, Comrade Boll': China fans hail German table tennis ace
-
G7 urges Middle East de-escalation as Trump makes hasty summit exit
-
With EuroPride, Lisbon courts LGBTQ travellers

The suffering of those who cannot feel pain
Patrice Abela first knew something was wrong when his eldest daughter was learning to walk and her feet left trails of blood behind her, yet she showed no sign of distress.
She was soon diagnosed with congenital insensitivity to pain, an extremely rare and dangerous genetic disorder that dooms sufferers to a lifetime of hurting themselves in ways they cannot feel.
Abela, a 55-year-old software developer in the southern French city of Toulouse, then watched in horror as his youngest daughter was revealed to have the same condition.
Now aged 12 and 13, the two girls spend around three months of every year in hospital.
"When they take a shower, they perceive hot and cold, but if it burns they don't feel anything," the father of four told AFP.
"Due to repeated infections, my eldest daughter lost the first joint of each of her fingers. She also had to have a toe amputated."
Repeated knee injuries have left both girls only able to move around using crutches or a wheelchair.
Abela said they may not feel physical pain but lamented their intense "psychological pain".
Aiming to raise awareness about the disease and "challenge the scientific community", Abela plans to run the equivalent of 90 marathons in fewer than four months. He plans to start on April 12, following the route of this year's Tour de France from Copenhagen to Paris.
- Danger everywhere -
A life without pain might sound like a dream come true but the reality is more like a nightmare.
There are only a few thousand known cases of the condition worldwide. The low number is believed to be partly due to sufferers often not living into adulthood.
"Pain plays a major physiological role in protecting us from the dangers of our environment," said Didier Bouhassira, a doctor at the centre for pain evaluation and treatment at Ambroise-Pare hospital in Paris.
In the most extreme cases, babies will "mutilate their tongue or fingers while teething", he told AFP.
Then comes "a lot of accidents, burns, walking on fractured limbs which heal badly", he added.
"They have to be taught what is innate in others: to protect themselves."
But when there are no warning signs, danger lurks everywhere.
Appendicitis, which announces itself in others via symptoms like pain and fever, can fester into a devastating general infection of the abdomen.
"Blindness can also occur because the eye must always be kept moist and the nervous system controls these processes via the so-called blink reflex," said Ingo Kurth of Germany's Institute of Human Genetics.
- New painkiller hopes -
Congenital insensitivity to pain (CIP) was first recognised in the 1930s, and numerous studies have since identified a genetic mutation that blocks a person's ability feel pain.
"We have learned that there are now more than 20 genetic causes of congenital or progressive insensitivity to pain," Kurth told AFP.
There is no cure and "no real drug breakthroughs have been made so far", Kurth said.
"But our understanding of the molecular causes of CIP continues to reveal new targets, and based on this, hopefully new therapies will be developed in the coming years."
There are also hopes that studying how CIP works could lead to the development of a new kind of painkiller, prompting huge interest from pharmaceutical giants seeking a fresh product in the billion-dollar industry of pain relief.
In this way, the unlucky few with CIP could contribute to the creation of a treatment that would help everyone in the world -- except themselves.
Y.Zaher--SF-PST